<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-9573</title>
	</head>
	<body>
		<main>
			<p>941115 FT  15 NOV 94 / UK Company News: Stega Pounds 6.7m flotation Stega Pharmaceuticals, a biotechnology company, hopes to raise Pounds 6.7m net from a flotation in London, according to its pathfinder prospectus published today. It is making a subscription offer of 1.9m shares at 400p each, representing 52.8 per cent of the company's enlarged equity and valuing the company at Pounds 14.4m. The company is applying to trade the shares under Rule 4.2. Stega, incorporated in Ireland but based in Linz, Austria, intends to use the proceeds to run clinical trials on a potential treatment for herpes virus infections. It will move its operations to the UK, where large numbers of clinical trials are conducted.</p>
		</main>
</body></html>
            